Preventive Healthcare And Advanced Diagnostics Will Shape Future Markets

Published
08 Aug 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$73.07
5.6% undervalued intrinsic discount
14 Aug
US$68.98
Loading
1Y
-14.8%
7D
3.1%

Author's Valuation

US$73.1

5.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Decreased 5.23%

Shared on30 Apr 25
Fair value Increased 2.09%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 0.81%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Decreased 1.94%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 1.42%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.37%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 13%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 3.07%